Johnson & Johnson and the Medicines Patent Pool

Johnson & Johnson formerly refused to negotiate any licensing agreements with the Medicines Patent Pool on December 19th, 2011.

Below, find a brief chronology of Johnson & Johnson's relationship with the Medicines Patent Pool including letters and statements leading up to J&J's latest refusal:

December 21, 2011 - MSF criticizes Johnson & Johnson for turning its back on PLHIV and refusing to join the MPP (links to

December 19, 2011 - MPP releases statement on Johnson & Johnson's refusal to negotiate (links to

December 19, 2011 - Johnson & Johnson sends letter to MPP refusing to participate in negotiations (links to

December 15, 2011 - Johnson & Johnson responds to Public Citizen's letter

December 15, 2011 - MSF organizes letter campaign requesting Johnson & Johnson to enter negotiations with the MPP (links to

December 7, 2011 - Public Citizen sends  Tibotec / Johnson & Johnson a letter urging them to negotiate with the MPP

April 25, 2011 - MSF press release on Johnson & Johnson's refusal to participate in the MPP (links to

April 25, 2011 - MSF writes Johnson & Johnson on their failure to license to the MPP (links to

January 31, 2011 - Johnson & Johnson declines the MPP's invitation to negotiations (links to

January 28, 2011 - MSF criticizes Johnson & Johnson / Tibotec voluntary licensing arrangements (links to

December 1, 2010 - The MPP writes Johnson & Johnson, inviting them to participate in negotiations (links to

Fall 2009-Fall 2010 - MSF writes Johnson & Johnson twice asking them to negotiate with the MPP


Click here to return to

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.